OR WAIT null SECS
Growth and Advancements in Fill/Finish
Leveraging automation advancements can help improve efficiency in aseptic processing.
Changes and Trends in the Outsourcing Landscape
Quality Considerations in Changing Excipient Providers
August 31, 2023
The Centers for Medicare & Medicaid Services (CMS) has announced the first 10 drugs covered under Medicare Part D selected for negotiation.
Bristol Myers Squibb’s Reblozyl (luspatercept-aamt) is approved as a first-line treatment for anemia in adults with lower-risk myelodysplastic syndromes.
The updated vaccine will be ready to ship following a positive European Commission review.
Extensive research on various gene editing techniques could inform the future of mRNA therapies.
Twist Bioscience is a synthetic biology and genomics company that has developed a DNA synthesis platform to industrialize the engineering of biology, which is a new method of this process by “writing” DNA on a silicon chip.
Exploring the state of pharma patents following the Supreme Court’s Amgen v. Sanofi decision.
August 30, 2023
The new products aim to aid consumers with menopause and eye health-related issues.
This is the first biosimilar to Tysabri, an injection for adults with multiple sclerosis.
Brandon McNaughton, founder and CEO of Akadeum Life Sciences, discusses his start-up’s unique microbubble separation technology.
August 29, 2023
Rentschler Biopharma, CGT Catapult, and Refeyn aim to use automated and digital technologies to improve AAV manufacturing for gene therapies.